EFFECTS OF CS-514 ON SERUM-LIPOPROTEIN LIPID AND APOLIPOPROTEIN LEVELS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA

被引：57
|
作者：
MABUCHI, H
KAMON, N
FUJITA, H
MICHISHITA, I
TAKEDA, M
KAJINAMI, K
ITOH, H
WAKASUGI, T
TAKEDA, R
机构：
来源：
METABOLISM-CLINICAL AND EXPERIMENTAL | 1987年 / 36卷 / 05期
关键词：
D O I：
10.1016/0026-0495(87)90046-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：475 / 479
页数：5
相关论文
共 50 条
  • [1] USEFULNESS OF COMBINED TREATMENT WITH CS-514(CS), PROBUCOL(PB) AND CHOLESTYRAMINE(CA) IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA(FH)
    NAKAMURA, T
    MATSUZAWA, Y
    FUNAHASHI, T
    YAMASHITA, S
    KUBO, M
    HIROBE, K
    NAKAJIMA, T
    TARUI, S
    ARTERIOSCLEROSIS, 1988, 8 (05): : A591 - A591
  • [2] SERUM-LIPID AND LIPOPROTEIN LEVELS IN JAPANESE PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    MABUCHI, H
    TATAMI, R
    UEDA, K
    UEDA, R
    HABA, T
    KAMETANI, T
    WATANABE, A
    WAKASUGI, T
    ITO, S
    KOIZUMI, J
    OHTA, M
    MIYAMOTO, S
    TAKEDA, R
    ATHEROSCLEROSIS, 1979, 32 (04) : 435 - 444
  • [3] EFFECTS OF PRAVASTATIN (CS-514) ON BILIARY LIPID-METABOLISM IN PATIENTS WITH HYPERLIPIDEMIA
    HORIUCHI, I
    OHYA, T
    TAZUMA, S
    MIZUNO, T
    TAKIZAWA, I
    KAJIYAMA, G
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (03): : 226 - 230
  • [4] TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH PRAVASTATIN (CS-514) AND OR CHOLESTYRAMINE - (THE SPANISH MULTICENTER PRAVASTATIN STUDY)
    CARMENA, R
    DEOYA, M
    FRANCO, M
    MARTINEZ, M
    MATA, P
    GOMEZ, J
    SERRANO, S
    ALVAREZSALA, L
    MATESANZ, J
    RUBIO, M
    GRAS, X
    ATHEROSCLEROSIS VIII, 1989, 817 : 757 - 760
  • [5] SERUM-LIPID AND APOLIPOPROTEIN-A AND APOLIPOPROTEIN-B LEVELS IN FAMILIAL HYPERCHOLESTEROLEMIA
    CRAIG, IH
    POULIS, P
    HILL, G
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1983, 13 (03): : 241 - 246
  • [6] EFFECTS OF CS-514 (EPTASTATIN), AN INHIBITOR OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A (HMG-COA) REDUCTASE, ON SERUM-LIPID AND APOLIPOPROTEIN LEVELS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS TREATED BY LOW-DENSITY LIPOPROTEIN (LDL)-APHERESISE
    MABUCHI, H
    FUJITA, H
    MICHISHITA, I
    TAKEDA, M
    KAJINAMI, K
    KOIZUMI, J
    TAKEDA, R
    TAKEGOSHI, T
    WAKASUGI, T
    UEDA, K
    MIYAMOTO, S
    WATANABE, A
    OOTA, M
    ATHEROSCLEROSIS, 1988, 72 (2-3) : 183 - 188
  • [7] EFFECTS OF CS-514 ON PLASMA-LIPIDS AND LIPOPROTEIN COMPOSITION IN HYPERCHOLESTEROLEMIC SUBJECTS
    YOSHINO, G
    KAZUMI, T
    IWAI, M
    IWATANI, I
    MATSUBA, K
    KASAMA, T
    MATSUSHITA, M
    OTSUKI, M
    BABA, S
    ATHEROSCLEROSIS, 1988, 71 (2-3) : 95 - 101
  • [8] 2-YEAR STUDY ON THE EFFECT OF PRAVASTATIN (CS-514) ON PLASMA-LIPOPROTEIN AND APOLIPOPROTEIN CONCENTRATIONS IN HYPERCHOLESTEROLEMIC PATIENTS
    YOSHINO, G
    MATSUSHITA, M
    IWAI, M
    UENOYAMA, R
    MATSUBA, K
    MORITA, M
    IWATANI, I
    KAZUMI, T
    BABA, S
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1989, 46 (01): : 144 - 152
  • [9] EFFECTS OF AMIODARONE ON SERUM-LIPOPROTEIN LEVELS
    ALBERT, SG
    ALVES, LE
    ROSE, EP
    AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (02): : 259 - 261
  • [10] EFFECTS OF PROBUCOL ON SERUM LIPOPROTEIN LEVELS AND VERY LOW-DENSITY APOLIPOPROTEIN COMPOSITIONS IN HETEROZYGOUS PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    ITO, H
    MABUCHI, H
    TAKEDA, R
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1985, 183 : 412 - 412
12345